InflaRx's Series B Round

InflaRx raised a round of funding on July 17, 2014.

InflaRx is a biopharmaceutical company developing new therapeutics in the terminal complement space. InflaRx focuses on applying its proprietary anti-C5a technology to discover and develop specific in…

Articles about InflaRx's Series B Round: